Addressing antimicrobial resistance demands more than technical solutions — it calls for convergence, collective action, and the courage to co-create. PCI India’s new knowledge platform is a step toward bridging that gap, bringing together diverse voices to turn insight into impact. Continue reading
The launch of NAP-AMR 2.0 marks a defining moment in India’s public health journey—a rare convergence of scientific insight, policy direction, and national urgency. Grounded in the principle of “One Health,” it recognizes a fundamental truth: antimicrobial resistance (AMR) is not confined to hospitals or clinical settings; it is equally rooted in agriculture, animal health, Continue reading
Microorganisms such as bacteria and viruses have repeatedly demonstrated an extraordinary ability to adapt and survive—often outpacing human innovation. History reminds us that almost every time a new antibiotic is introduced, bacteria eventually develop mechanisms to resist it. With a limited pipeline of new antibiotics and growing resistance, the challenge of treating infections is becoming Continue reading
Lorem ipsum dolor sit amet, consectetur adipiscing elit
Lorem ipsum dolor sit amet, consectetur adipiscing elit
Lorem ipsum dolor sit amet, consectetur adipiscing elit